Clinical Trials List
Protocol Number1478-0002
Completed
2023-09-01 - 2027-07-31
Phase II
Not yet recruiting2
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- JEN-KUANG LEE 無
- Yi-Chih Wang 無
- 鄭人方 無
- 孟士瑋 無
- YEN-HUNG LIN 無
- 江君揚 無
- 林柏志 無
- 蔡承烜 無
- 洪啟盛 無
- CHO-KAI WU 無
- 陳盈憲 無
- 柯宗佑 無
- WEI-TIEN CHANG 無
- Chih-Fan Yeh 無
- MAO-HSIN LIN 無
- 黃慶昌 無
- WenJeng Lee 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
350 participants
